Performant Healthcare Research and Development Expenses 2011-2025 | PHLT

Performant Healthcare research and development expenses from 2011 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
Performant Healthcare Annual Research and Development Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
Performant Healthcare Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $0.267B $0.123B
Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $139.155B 26.10
Elevance Health (ELV) United States $84.931B 10.96
CVS Health (CVS) United States $84.554B 10.51
Cencora (COR) United States $57.517B 20.01
Natera (NTRA) United States $23.347B 0.00
DiDi Global (DIDIY) China $22.403B 23.80
Labcorp Holdings (LH) United States $21.878B 17.75
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.676B 0.00
Solventum (SOLV) United States $12.566B 13.30
CochLear (CHEOY) Australia $12.083B 0.00
ICON (ICLR) Ireland $11.595B 10.78
Revvity (RVTY) United States $11.128B 19.15
Doximity (DOCS) United States $10.714B 49.60
Viatris (VTRS) United States $10.293B 3.54
Avantor (AVTR) United States $9.056B 13.16
HealthEquity (HQY) United States $8.820B 38.64
Medpace Holdings (MEDP) United States $8.700B 23.11
Sonic Healthcare (SKHHY) Australia $8.407B 0.00
Charles River Laboratories (CRL) United States $7.136B 13.98
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.085B 24.06
BrightSpring Health Services (BTSG) United States $3.934B 36.10
Sotera Health (SHC) United States $3.105B 17.65
Alignment Healthcare (ALHC) United States $2.849B 0.00
Concentras Parent (CON) United States $2.676B 15.47
Organon (OGN) United States $2.568B 2.73
Surgery Partners (SGRY) United States $2.542B 33.06
PACS (PACS) United States $2.027B 0.00
Progyny (PGNY) United States $1.856B 40.85
Ardent Health (ARDT) United States $1.854B 7.90
GeneDx Holdings (WGS) United States $1.838B 70.80
Premier (PINC) United States $1.834B 13.92
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.230B 0.00
Pediatrix Medical (MD) United States $1.147B 8.73
Establishment Labs Holdings (ESTA) $1.100B 0.00
CareDx (CDNA) United States $1.060B 16.55
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.902B 0.00
AMN Healthcare Services Inc (AMN) United States $0.856B 8.01
QDM (QDMI) Hong Kong, SAR China $0.758B 0.00
LifeMD (LFMD) United States $0.684B 0.00
Nutex Health (NUTX) United States $0.661B 10.01
Embecta (EMBC) United States $0.569B 3.83
InnovAge Holding (INNV) United States $0.512B 0.00
SBC Medicals (SBC) United States $0.482B 0.00
Enhabit (EHAB) United States $0.473B 38.92
Auna S.A (AUNA) Luxembourg $0.459B 10.33
Sonida Senior Living (SNDA) United States $0.454B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.449B 0.00
Omada Health (OMDA) $0.399B 0.00
Oncology Institute (TOI) United States $0.212B 0.00
Beauty Health (SKIN) United States $0.184B 0.00
DocGo (DCGO) United States $0.165B 27.00
Pheton Holdings (PTHL) China $0.119B 0.00
So-Young (SY) China $0.102B 0.00
KindlyMD (NAKA) United States $0.084B 0.00
Sera Prognostics (SERA) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.053B 0.00
ModivCare (MODV) United States $0.052B 0.00
Basel Medical Group (BMGL) Singapore $0.049B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.034B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00